Mitsubishi UFJ Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Mitsubishi UFJ Securities’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-530	Closed	-$116K	–	76
2019 Q4	$116K	Hold	530	–	–	0.62%	33
2019 Q3	$90K	Hold	530	–	–	0.43%	42
2019 Q2	$97K	Hold	530	–	–	0.32%	84
2019 Q1	$97K	Hold	530	–	–	0.55%	35
2018 Q4	$88K	Sell	530 -100	-16%	-$17.3K	0.66%	44
2018 Q3	$121K	Hold	630	–	–	0.39%	52
2018 Q2	$107K	Hold	630	–	–	0.38%	53
2018 Q1	$103K	Hold	630	–	–	0.4%	62
2017 Q4	$94K	Sell	630 -110	-15%	-$16.3K	0.39%	61
2017 Q3	$113K	Buy	740 +280	+61%	+$42.1K	0.54%	50
2017 Q2	$59K	Buy	460 +210	+84%	+$25.3K	0.32%	79
2017 Q1	$27K	Hold	250	–	–	0.15%	120
2016 Q4	$18K	Hold	250	–	–	0.1%	129
2016 Q3	$22K	Hold	250	–	–	0.12%	108
2016 Q2	$22K	Hold	250	–	–	0.04%	141
2016 Q1	$20K	Sell	250 -180	-42%	-$16.3K	0.03%	148
2015 Q4	$54K	Sell	430 -450	-51%	-$54.3K	0.08%	88
2015 Q3	$92K	Buy	880 +600	+214%	+$77.1K	0.65%	24
2015 Q2	$35K	Sell	280 -10	-3%	-$1.26K	0.24%	98
2015 Q1	$34K	Buy	+290	New	+$34.7K	0.09%	98

Other funds holding VRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mitsubishi UFJ Securities's VRTX Position: Q1 2020 in Review

Mitsubishi UFJ Securities sold out of Vertex Pharmaceuticals (VRTX) in Q1 2020, closing a stake of 530 shares — an estimated $116K sold.

Mitsubishi UFJ Securities first reported a position in VRTX in Q1 2015 and held it in 20 quarters. The position peaked at $121K in Q3 2018. 855 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

Mitsubishi UFJ Securities reported no remaining Vertex Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Mitsubishi UFJ Securities sold 530 Vertex Pharmaceuticals shares in Q1 2020, an estimated $116K.
Mitsubishi UFJ Securities first reported a position in Vertex Pharmaceuticals in Q1 2015 and held it in 20 quarters.
Mitsubishi UFJ Securities's Vertex Pharmaceuticals position peaked at $121K in Q3 2018.
855 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Mitsubishi UFJ Securities's 13F filing for Q1 2020, filed 13 May 2020.